Reported
Lowest–highest estimate
The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
S
Svas Biosana SpA
MIL:SVS
Svas Biosana SpA
MIL:SVS
Price:
8
EUR
Market Cap:
€42.7m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
S
|
Svas Biosana SpA
MIL:SVS
|
IT |
|
Abbott Laboratories
NYSE:ABT
|
US |
|
H
|
Healius Ltd
F:PGZ
|
AU |
|
Prim SA
F:5P1
|
ES |
|
Mistras Group Inc
F:MIY
|
US |
|
Eutelsat Communications SA
PAR:ETL
|
FR |
|
SHIFT Inc
F:7CZ
|
JP |
|
N
|
Nuenergy Gas Ltd
F:NUB
|
AU |
|
Noodles & Co
NASDAQ:NDLS
|
US |
|
Supremex Inc
TSX:SXP
|
CA |
|
R
|
Ramkhamhaeng Hospital PCL
SET:RAM
|
TH |
|
B
|
Bursa Cimento Fabrikasi AS
IST:BUCIM.E
|
TR |
|
Phoenix Mills Ltd
NSE:PHOENIXLTD
|
IN |
|
C
|
Coles Group Ltd
F:2OF
|
AU |
|
Xali Gold Corp
F:I970
|
CA |
|
Cedar Fair LP
NYSE:FUN
|
US |
|
Y
|
Yiwu Huading Nylon Co Ltd
SSE:601113
|
CN |
|
Baxter International Inc
NYSE:BAX
|
US |
|
Dno ASA
OSE:DNO
|
NO |
|
C
|
China Chengtong Development Group Ltd
F:CCO
|
HK |
|
DGR Global Ltd
ASX:DGR
|
AU |
|
Focus Graphite Inc
XTSX:FMS
|
CA |
Wall St Price Targets
SVS Price Forecast
Based on 3 analysts
Based on 3 analysts
+53% Upside
from
€8
today
Svas Biosana SpA (SVS)’s 12-month stock price forecast through October 2027 has a consensus target of €12.24, implying 53% upside. The forecast is based on price targets from 3 Wall Street analysts.
Svas Biosana SpA Competitors:
Price Targets
Price Targets
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is SVS's stock price target?
Price Target
12.24
EUR
12.24
EUR
According to Wall Street analysts, the average 1-year price target for SVS is 12.24 EUR with a low forecast of 12.12 EUR and a high forecast of 12.6 EUR.
What is the Revenue forecast for Svas Biosana SpA?
Projected CAGR
5%
5%
Over the last 6 years, the compound annual growth rate for Revenue has been 11%. The projected CAGR for the next 3 years is 5%.
What is the Gross Profit forecast for Svas Biosana SpA?
Projected CAGR
-1%
-1%
Over the last 6 years, the compound annual growth rate for Gross Profit has been 9%. The projected CAGR for the next 3 years is -1%.
What is the Operating Income forecast for Svas Biosana SpA?
Projected CAGR
5%
5%
Over the last 6 years, the compound annual growth rate for Operating Income has been 16%. The projected CAGR for the next 3 years is 5%.
What is the Pre-Tax Income forecast for Svas Biosana SpA?
Projected CAGR
15%
15%
Over the last 6 years, the compound annual growth rate for Pre-Tax Income has been 19%. The projected CAGR for the next -3 years is 15%.
What is the Net Income forecast for Svas Biosana SpA?
Projected CAGR
8%
8%
Over the last 6 years, the compound annual growth rate for Net Income has been 18%. The projected CAGR for the next 3 years is 8%.